Paul Volberding, MD

Title(s)Professor Emeritus, Epidemiology & Biostatistics
SchoolSchool of Medicine
Phone415-476-5470
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of MinnesotaM.D.1975
    University of ChicagoA.B.1971
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    Institute of Medicine1999Member
    American College of Physicians2015Master

    Collapse Overview 
    Collapse Overview
    I was trained in Medical Oncology but became involved in the early AIDS epidemic in San Francisco based at San Francisco General Hospital. I have worked in clinical trials in HIV-related malignancies but primarily in the development of antiretroviral therapy. I was the PI and co-director with Warner Greene of the NIAID-funded UCSF-Gladstone Center for AIDS Research supporting the large community of HIV investigators in San Francisco. CFAR provides core services, pilot grants to early career stage investigators and supports a comprehensive mentorship program. In the Clinical and Translational Sciences Institute I served as a member of the Board of Directors and formerly directed the Global Health Program. I stepped down as the Chief of the Medical Service at the San Francisco VA Medical Center in 2012 to become the Director of the UCSF AIDS Research Institute. The ARI is the comprehensive University organization that links all HIV/AIDS research programs and is the central focus for communications, media relations and philanthropic support for this internationally recognized response to the HIV epidemic. In 2015, the ARI became the administrative home for a unique initiative to cure HIV infection funded by amfAR, the Foundation for AIDS Research. I served until recently as the Director of the amfAR Institute for HIV Cure, working with leading scientists at UCSF, the Gladstone Institute for Virology and Immunology, and the Vitalant (formerly the Blood Systems) Research Institute. I also served as the Associate Chair of the UCSF Department of Medicine for Global Health. I am the Clinical Editor in Chief of the Journal of the Acquired Immunodeficiency Syndromes and served as the Chair of the Scientific Advisory Board of the Accordia Global AIDS Foundation and the Infectious Diseases Institute at Makerere University in Kampala Uganda. I was a board member of the Pangaea Global AIDS Foundation. I am an active member of the National Academy of Medicine (formerly the Institute of Medicine) of the National Academy of Sciences and am the founding Board Chair of the International Antiviral Society-USA. On Twitter I am @pvolberding.
    Collapse In The News
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Recent Advances in AIDS and HIV Research
    NIH R13AI102630Sep 1, 2012 - Aug 31, 2022
    Role: Principal Investigator
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - May 31, 2023
    Role: Co-Investigator
    SIXTH INTERNATIONAL CONFERENCE ON AIDS
    NIH R13AI029901Apr 1, 1990 - Mar 31, 1991
    Role: Principal Investigator
    UCSF-Gladstone Center for AIDS Research
    NIH P30AI027763Sep 30, 1988 - Aug 31, 2022
    Role: Principal Investigator
    UCSF-GIVI CENTER FOR AIDS RESEARCH
    NIH P30MH059037Sep 30, 1988 - Feb 28, 2003
    Role: Principal Investigator
    LABORATORY AND CLINICAL STUDIES OF AIDS
    NIH P01AI024286Feb 1, 1987 - Jun 30, 1992
    Role: Principal Investigator
    SURAMIN IN PATIENTS WITH AIDS AND AIDS RELATED ILLNESSES
    NIH/NIAID N01AI062510Dec 6, 1985
    Role: Principal Investigator
    STUDIES OF ACQUIRED IMMUNE DEFICIENCY SYNDROME
    NIH U01CA034980May 1, 1983 - Apr 30, 1987
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Academic Senate

    Collapse Featured Content 
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A roadmap to establishing global oncology as a priority initiative within a National Cancer Institute-designated cancer center. J Natl Cancer Inst. 2024 Mar 07; 116(3):345-351. Van Loon K, Breithaupt L, Ng D, DeBoer RJ, Buckle GC, Bialous S, Hiatt RA, Volberding P, Hermiston ML, Ashworth A. PMID: 38060289; PMCID: PMC10919326.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruption. Sci Transl Med. 2023 05 10; 15(695):eabq4490. Esmaeilzadeh E, Etemad B, Lavine CL, Garneau L, Li Y, Regan J, Wong C, Sharaf R, Connick E, Volberding P, Sagar M, Seaman MS, Li JZ. PMID: 37163616; PMCID: PMC10576978.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    3. HIV post-treatment controllers have distinct immunological and virological features. Proc Natl Acad Sci U S A. 2023 03 14; 120(11):e2218960120. Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, Volberding P, Connick E, Mitsuyasu R, Frank I, Saag M, Eron JJ, Skiest D, Margolis DM, Havlir D, Schooley RT, Lederman MM, Yu XG, Li JZ. PMID: 36877848; PMCID: PMC10089217.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    4. Transcriptomic Signatures of Human Immunodeficiency Virus Post-Treatment Control. J Virol. 2023 01 31; 97(1):e0125422. Wedrychowski A, Martin HA, Li Y, Telwatte S, Kadiyala GN, Melberg M, Etemad B, Connick E, Jacobson JM, Margolis DM, Skiest D, Volberding P, Hecht F, Deeks S, Wong JK, Li JZ, Yukl SA. PMID: 36541802; PMCID: PMC9888280.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    5. Sexual Practice Changes Post-HIV Diagnosis Among Men Who Have Sex with Men in the United States: A Systematic Review and Meta-analysis. AIDS Behav. 2023 Jan; 27(1):257-278. Malekinejad M, Jimsheleishvili S, Barker EK, Hutchinson AB, Shrestha RK, Volberding P, Kahn JG. PMID: 35829969; PMCID: PMC9834435.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Is France Once Again Looking for a Scapegoat? Pathog Immun. 2021; 6(2):149-152. Lederman MM, Flier JS, Hale P, Haase AT, Powderly W, Reiss P, Silvestri G, Sekaly RP, Paiardini M, Weissman D, Kuritzkes DR, Calabrese LH, Agre P, Reyes-Teran G, Landay AL, Lewin S, Richman DD, Volberding P, Hunt PW, Schechter M. PMID: 35097250; PMCID: PMC8792773.
      View in: PubMed   Mentions:
    7. Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. AIDS. 2021 11 01; 35(13):2225-2227. Fajnzylber J, Sharaf R, Hutchinson JN, Aga E, Bosch RJ, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest DJ, Margolis D, Sneller MC, Little SJ, Gulick RM, Mellors JW, Gandhi RT, Schooley RT, Henry K, Tebas P, Deeks S, Chun TW, Collier AC, Hecht FM, Li JZ, CHAMP study team. PMID: 34127579; PMCID: PMC8490281.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. Drug Alcohol Depend. 2021 02 01; 219:108481. Satre DD, Levine-Hall T, Sterling SA, Young-Wolff KC, Lam JO, Alexeeff S, Hojilla JC, Williams A, Justice AC, Sterne J, Cavassini M, Bryant KJ, Williams EC, Horberg MA, Volberding P, Weisner C, Silverberg MJ. PMID: 33429295; PMCID: PMC7869693.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    9. Change in Condom Use in Populations Newly Aware of HIV Diagnosis in the United States and Canada: A Systematic Review and Meta-Analysis. AIDS Behav. 2021 Jun; 25(6):1839-1855. Malekinejad M, Blodgett J, Horvath H, Parriott A, Hutchinson AB, Shrestha RK, McCabe D, Volberding P, Kahn JG. PMID: 33389321; PMCID: PMC9239206.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030. Satre DD, Parthasarathy S, Silverberg MJ, Horberg M, Young-Wolff KC, Williams EC, Volberding P, Campbell CI. PMID: 33176760; PMCID: PMC7656679.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2020 10 27; 324(16):1651-1669. Saag MS, Gandhi RT, Hoy JF, Landovitz RJ, Thompson MA, Sax PE, Smith DM, Benson CA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 33052386; PMCID: PMC11017368.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCellsPHPublic Health
    12. Sharing Experiences and Lessons: Medical Issues in Confronting the HIV Epidemic and COVID-19. Int J Radiat Oncol Biol Phys. 2020 10 01; 108(2):343-345. Volberding P. PMID: 32890507; PMCID: PMC7462836.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. Antiretroviral drug class and anaemia risk in the current treatment era among people living with HIV in the USA: a clinical cohort study. BMJ Open. 2020 03 19; 10(3):e031487. Harding BN, Whitney BM, Nance RM, Crane HM, Burkholder G, Moore RD, Mathews WC, Eron JJ, Hunt PW, Volberding P, Rodriguez B, Mayer K, Saag MS, Kitahata MM, Heckbert SR, Delaney JAC. PMID: 32198297; PMCID: PMC7103836.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Antimicrobial Drug Development Efficiency and Surrogate Markers of Clinical Benefit. JAMA Intern Med. 2020 01 01; 180(1):138-139. Volberding P, Chambers HF. PMID: 31710332.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. National Academies Consensus Report on Functional Assessment for Adults With Disabilities. Arch Phys Med Rehabil. 2019 12; 100(12):2407-2408. Heinemann AW, Volberding PA. PMID: 31767062.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial. Contemp Clin Trials. 2019 09; 84:105833. Satre DD, Anderson AN, Leibowitz AS, Levine-Hall T, Slome S, Flamm J, Hare CB, McNeely J, Weisner CM, Horberg MA, Volberding P, Silverberg MJ. PMID: 31446142; PMCID: PMC6760257.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    17. Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial. J Gen Intern Med. 2019 10; 34(10):2054-2061. Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, Lam JO, Bryant KJ, Weisner CM, Sterling SA, Horberg M, Volberding P, Silverberg MJ. PMID: 31187344; PMCID: PMC6816606.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    18. HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence. JAMA. 2019 06 11; 321(22):2172-2174. Scott H, Volberding PA. PMID: 31184721.
      View in: PubMed   Mentions: 4     Fields:    Translation:CellsPHPublic Health
    19. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States. Open Forum Infect Dis. 2019 Jan; 6(1):ofy353. Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. PMID: 30931346; PMCID: PMC6346293.
      View in: PubMed   Mentions: 14  
    20. The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis. 2018 11 05; 218(12):1954-1963. Namazi G, Fajnzylber JM, Aga E, Bosch RJ, Acosta EP, Sharaf R, Hartogensis W, Jacobson JM, Connick E, Volberding P, Skiest D, Margolis D, Sneller MC, Little SJ, Gianella S, Smith DM, Kuritzkes DR, Gulick RM, Mellors JW, Mehraj V, Gandhi RT, Mitsuyasu R, Schooley RT, Henry K, Tebas P, Deeks SG, Chun TW, Collier AC, Routy JP, Hecht FM, Walker BD, Li JZ. PMID: 30085241; PMCID: PMC6217727.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    21. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018 08 31; 128(9):4074-4085. Sharaf R, Lee GQ, Sun X, Etemad B, Aboukhater LM, Hu Z, Brumme ZL, Aga E, Bosch RJ, Wen Y, Namazi G, Gao C, Acosta EP, Gandhi RT, Jacobson JM, Skiest D, Margolis DM, Mitsuyasu R, Volberding P, Connick E, Kuritzkes DR, Lederman MM, Yu XG, Lichterfeld M, Li JZ. PMID: 30024859; PMCID: PMC6118642.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    22. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018 07 24; 320(4):379-396. Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP, Del Rio C, Eron JJ, Fätkenheuer G, Günthard HF, Molina JM, Jacobsen DM, Volberding PA. PMID: 30043070; PMCID: PMC6415748.
      View in: PubMed   Mentions: 255     Fields:    Translation:Humans
    23. Effect of Short-Term Antiretroviral Therapy Interruption on Levels of Integrated HIV DNA. J Virol. 2018 06 15; 92(12). Strongin Z, Sharaf R, VanBelzen DJ, Jacobson JM, Connick E, Volberding P, Skiest DJ, Gandhi RT, Kuritzkes DR, O'Doherty U, Li JZ. PMID: 29593048; PMCID: PMC5974505.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    24. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122; PMCID: PMC5677050.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. PMID: 28771484; PMCID: PMC5542551.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    26. How to Survive a Plague: The Next Great HIV/AIDS History. JAMA. 2017 04 04; 317(13):1298-1299. Volberding PA. PMID: 28384806.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    27. HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel. Top Antivir Med. 2017 Feb/Mar; 25(1):17-24. Volberding PA. PMID: 28402930; PMCID: PMC5677040.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. JAIDS: Transitions, Evolution, and Impact. J Acquir Immune Defic Syndr. 2017 01 01; 74(1):1-2. Volberding P, Blattner WA. PMID: 27926666; PMCID: PMC5144919.
      View in: PubMed   Mentions:    Fields:    
    29. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI. PMID: 27749602; PMCID: PMC5110373.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    30. Facilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals. BMC Public Health. 2016 09 20; 16:994. Rich ZC, Chu C, Mao J, Zhou K, Cai W, Ma Q, Volberding P, Tucker JD. PMID: 27645935; PMCID: PMC5029046.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    31. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2017 01; 19(1):99-108. Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL. PMID: 27576871; PMCID: PMC5193026.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Health impact of human rights testimony: harming the most vulnerable? BMJ Glob Health. 2016; 1(1):e000001. Meffert SM, Shome S, Neylan TC, Musalo K, Fineberg HV, Cooke MM, Volberding PA, Goosby EP. PMID: 28588904; PMCID: PMC5321303.
      View in: PubMed   Mentions:    Fields:    
    33. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2016 Jul 12; 316(2):191-210. Günthard HF, Saag MS, Benson CA, del Rio C, Eron JJ, Gallant JE, Hoy JF, Mugavero MJ, Sax PE, Thompson MA, Gandhi RT, Landovitz RJ, Smith DM, Jacobsen DM, Volberding PA. PMID: 27404187; PMCID: PMC5012643.
      View in: PubMed   Mentions: 271     Fields:    Translation:HumansCellsPHPublic Health
    34. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion. Open Forum Infect Dis. 2016 Apr; 3(2):ofw065. Chu CE, Wu F, He X, Zhou K, Cheng Y, Cai W, Geng E, Volberding P, Tucker JD. PMID: 27419150; PMCID: PMC4943171.
      View in: PubMed   Mentions: 5  
    35. Crowdsourcing HIV Test Promotion Videos: A Noninferiority Randomized Controlled Trial in China. Clin Infect Dis. 2016 06 01; 62(11):1436-1442. Tang W, Han L, Best J, Zhang Y, Mollan K, Kim J, Liu F, Hudgens M, Bayus B, Terris-Prestholt F, Galler S, Yang L, Peeling R, Volberding P, Ma B, Xu H, Yang B, Huang S, Fenton K, Wei C, Tucker JD. PMID: 27129465; PMCID: PMC4872295.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    36. Building Networks for Global Clinical Research: The Basics. J Orthop Trauma. 2015 Dec; 29 Suppl 12:S15-8. Shearer DW, Volberding PA, Schemitsch EH, Cook GE, Slobogean GP, Morshed S. PMID: 26584260.
      View in: PubMed   Mentions:    Fields:    
    37. Exploring the social meaning of curing HIV: a qualitative study of people who inject drugs in Guangzhou, China. AIDS Res Hum Retroviruses. 2015 Jan; 31(1):78-84. Chu CE, Wu F, He X, Ma Q, Cheng Y, Cai W, Volberding P, Tucker JD. PMID: 25427547; PMCID: PMC4287130.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    38. Implementing Implementation Science: An Approach for HIV Prevention, Care and Treatment Programs. Curr HIV Res. 2015; 13(3):244-9. Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, Udoh IC, Cattamanchi A, Geng EH, Volberding P. PMID: 25986374; PMCID: PMC4460284.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    39. Highlights of the 2014 International AIDS Conference: update from down under. Top Antivir Med. 2014 Dec-2015 Jan; 22(5):694-7. Volberding PA. PMID: 25612178; PMCID: PMC6148894.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Words matter: Discussing research towards an HIV cure in research and clinical contexts. J Acquir Immune Defic Syndr. 2014 Nov 01; 67(3):e110-1. Tucker JD, Volberding PA, Margolis DM, Rennie S, Barré-Sinoussi F. PMID: 25314254; PMCID: PMC4199082.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    41. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. JAMA. 2014 Jul 23-30; 312(4):410-25. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA, International Antiviral Society-USA Panel. PMID: 25038359.
      View in: PubMed   Mentions: 226     Fields:    Translation:Humans
    42. HIV cure: the target is clearer but not yet close. Ann Intern Med. 2014 Apr 01; 160(7):505-6. Volberding P. PMID: 24424733.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    43. Solving the mystery of JAIDS. J Acquir Immune Defic Syndr. 2013 Aug 01; 63(4):417. Volberding PA. PMID: 23722609.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. Bringing the end in sight: consensus regarding HIV screening strategies. Ann Intern Med. 2013 Jul 02; 159(1):63-4. Das M, Volberding P. PMID: 23698261.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    45. A chronicle of hope and promise: the world as it was, as it is, and as it can be. J Acquir Immune Defic Syndr. 2012 Aug 15; 60 Suppl 3:S49-50. El-Sadr WM, Morrison JS, Quinn T, Volberding P. PMID: 22797739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012 Jul 25; 308(4):387-402. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, Eron JJ, Günthard HF, Hammer SM, Reiss P, Richman DD, Rizzardini G, Thomas DL, Jacobsen DM, Volberding PA. PMID: 22820792.
      View in: PubMed   Mentions: 363     Fields:    Translation:Humans
    47. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P, OAR Working Group on HIV and Aging. PMID: 22688010; PMCID: PMC3413877.
      View in: PubMed   Mentions: 299     Fields:    Translation:Humans
    48. Augmented HIV-specific interferon-gamma responses, but impaired lymphoproliferation during interruption of antiretroviral treatment initiated in primary HIV infection. J Acquir Immune Defic Syndr. 2011 Sep 01; 58(1):1-8. Connick E, Bosch RJ, Aga E, Schlichtemeier R, Demeter LM, Volberding P, ACTG 709 Team. PMID: 21637110; PMCID: PMC3159837.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    49. Clinician attitudes about commercial support of continuing medical education: results of a detailed survey. Arch Intern Med. 2011 May 09; 171(9):840-6. Tabas JA, Boscardin C, Jacobsen DM, Steinman MA, Volberding PA, Baron RB. PMID: 21555662.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    50. HIV and premature aging: A field still in its infancy. Ann Intern Med. 2010 Oct 05; 153(7):477-9. Martin J, Volberding P. PMID: 20921548.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    51. Prevalence of primary resistance at baseline in acutely and recently infected subjects enrolled in AIDS clinical trials group protocol 371. J Acquir Immune Defic Syndr. 2010 Sep; 55(1):132-4. Dykes C, Mukherjee AL, Bosch RJ, Connick E, Volberding PA, Demeter LM. PMID: 20733405; PMCID: PMC2928582.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    52. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010 Jul 21; 304(3):321-33. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, Gatell JM, Günthard HF, Hammer SM, Hirsch MS, Jacobsen DM, Reiss P, Richman DD, Volberding PA, Yeni P, Schooley RT, International AIDS Society-USA. PMID: 20639566.
      View in: PubMed   Mentions: 326     Fields:    Translation:HumansCells
    53. Antiretroviral therapy and management of HIV infection. Lancet. 2010 Jul 03; 376(9734):49-62. Volberding PA, Deeks SG. PMID: 20609987.
      View in: PubMed   Mentions: 180     Fields:    Translation:Humans
    54. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int. 2010 Sep; 78(5):478-85. Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. PMID: 20520594; PMCID: PMC3913062.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    55. Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010 Feb 09; 121(5):651-8. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG. PMID: 20100969; PMCID: PMC2829672.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    56. Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS. 2009 Sep 24; 23(15):1987-95. Volberding P, Demeter L, Bosch RJ, Aga E, Pettinelli C, Hirsch M, Vogler M, Martinez A, Little S, Connick E, ACTG 371 Team. PMID: 19696651; PMCID: PMC2888600.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCellsCTClinical Trials
    57. Cohorts, trials, and evidence: expanding our confidence in guidelines for antiretroviral resistance testing. Ann Intern Med. 2009 Jul 21; 151(2):135-6. Volberding P. PMID: 19620166.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    58. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008 Aug 06; 300(5):555-70. Hammer SM, Eron JJ, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA, International AIDS Society-USA. PMID: 18677028.
      View in: PubMed   Mentions: 336     Fields:    Translation:HumansCells
    59. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease. Clin Infect Dis. 2007 Dec 15; 45(12):1633-9. Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM. PMID: 18190326.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    60. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007 Nov; 18(11):2968-74. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. PMID: 17942954.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    61. Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. Clin Infect Dis. 2007 May 15; 44(10):1375-83. Behler CM, Vittinghoff E, Lin F, Chung RT, Peters MG, Robbins GK, Volberding PA. PMID: 17443478; PMCID: PMC4075655.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    62. Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004). J Acquir Immune Defic Syndr. 2007 Jan 01; 44(1):20-9. Holodniy M, Hornberger J, Rapoport D, Robertus K, MaCurdy TE, Lopez J, Volberding P, Deyton L. PMID: 17091020.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    63. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006 Aug 16; 296(7):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA, International AIDS Society-USA panel. PMID: 16905788.
      View in: PubMed   Mentions: 176     Fields:    Translation:HumansCells
    64. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. Top HIV Med. 2006 Aug-Sep; 14(3):827-43. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA, International AIDS Society--USA Panel. PMID: 17016878.
      View in: PubMed   Mentions: 45     Fields:    
    65. The New York case: lessons being learned. Ann Intern Med. 2005 May 17; 142(10):866-8. Volberding PA. PMID: 15845950.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    66. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses. 2005 Mar; 21(3):200-6. Behler C, Shade S, Gregory K, Abrams D, Volberding P. PMID: 15795525.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    67. Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up. Transplantation. 2004 Dec 15; 78(11):1582-9. Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST. PMID: 15591945.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    68. Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. J Acquir Immune Defic Syndr. 2004 Oct 01; 37(2):1221-7. Henry DH, Volberding PA, Leitz G. PMID: 15385728.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med. 2004 Jul 29; 351(5):451-9. Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C, AIDS Clinical Trials Group A5071 Study Team. PMID: 15282352; PMCID: PMC4113392.
      View in: PubMed   Mentions: 213     Fields:    Translation:HumansCellsCTClinical Trials
    70. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel. JAMA. 2004 Jul 14; 292(2):251-65. Yeni PG, Hammer SM, Hirsch MS, Saag MS, Schechter M, Carpenter CC, Fischl MA, Gatell JM, Gazzard BG, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 15249575.
      View in: PubMed   Mentions: 121     Fields:    Translation:Humans
    71. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis. 2004 May 15; 38(10):1454-63. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M, Anemia in HIV Working Group. PMID: 15156485.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    72. Initiating HIV therapy. Timing is critical, controversial. Postgrad Med. 2004 Feb; 115(2):15-8, 21, 24-6. Volberding PA. PMID: 15000057.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Opportunities and options for treatment research in resource-constrained settings. Clin Infect Dis. 2003 Jul 01; 37(Suppl 1):S1-3. Volberding PA. PMID: 12822126.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. The pavia consensus statement. AIDS. 2003 Apr; 17 Suppl 1:S170-9. Volberding PA, Murphy RL, Barbaro G, Barbarini G, Bruno R, Cirelli A, Currie PF, Di Lorenzo G, Fantoni M, Filiced G, Galli M, Grisorio B, Moroni M, Recusani F, Sacchi P, Scevola D, Stein JH, Torre D, Vittecoq D. PMID: 12870544.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    75. HIV therapy in 2003: consensus and controversy. AIDS. 2003 Apr; 17 Suppl 1:S4-11. Volberding PA. PMID: 12870525.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    76. A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS. 2003 Mar 28; 17(5):691-8. Lalezari JP, Eron JJ, Carlson M, Cohen C, DeJesus E, Arduino RC, Gallant JE, Volberding P, Murphy RL, Valentine F, Nelson EL, Sista PR, Dusek A, Kilby JM. PMID: 12646792.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCellsCTClinical Trials
    77. Human immunodeficiency virus hematology. Hematology Am Soc Hematol Educ Program. 2003; 294-313. Volberding PA, Baker KR, Levine AM. PMID: 14633787.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    78. What can modeling tell us about the threat of antiviral drug resistance? Curr Opin Infect Dis. 2002 Dec; 15(6):609-14. Blower S, Volberding P. PMID: 12821838.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    79. Adherence, resistance, and timing: current issues in the use of new therapies. AIDS Read. 2002 Aug; 12(8):349-50, 356-7, 368. Volberding P. PMID: 12229892.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    80. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2002 Jul 10; 288(2):222-35. Yeni PG, Hammer SM, Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner JS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Volberding PA. PMID: 12095387.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    81. Does hepatitis C virus infection increase the risk of HIV disease progression? JAMA. 2002 Jul 10; 288(2):241-3. Rossi SJ, Volberding PA, Wright TL. PMID: 12095390.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    82. The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults. AIDS Res Hum Retroviruses. 2002 Jul 01; 18(10):685-93. Kilby JM, Lalezari JP, Eron JJ, Carlson M, Cohen C, Arduino RC, Goodgame JC, Gallant JE, Volberding P, Murphy RL, Valentine F, Saag MS, Nelson EL, Sista PR, Dusek A. PMID: 12167274.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCellsCTClinical Trials
    83. The impact of anemia on quality of life in human immunodeficiency virus-infected patients. J Infect Dis. 2002 May 15; 185 Suppl 2:S110-4. Volberding P. PMID: 12001031.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    84. Introduction: the importance of identifying and treating complications of human immunodeficiency virus disease. J Infect Dis. 2002 May 15; 185 Suppl 2:S103-4. Volberding P, Sullivan P. PMID: 12001029.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    85. Who cares for AIDS? J Gen Intern Med. 2002 Jan; 17(1):82-3. Volberding PA. PMID: 11903780; PMCID: PMC1495001.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Paul's Networks
    Concepts (284)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (59)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.